SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFih Group Regulatory News (FIH)

Share Price Information for Fih Group (FIH)

Share Price is delayed by 15 minutes
Get Live Data
205.00    0.00 (0.00%)
Bid:
200.00
Ask:
210.00
Spread: 10.00 (5.00%)
Market Cap: £25.67m
FIH Live PriceLast checked at - London Stock Exchange

Intraday Fih Group Share Chart

Form 8.5 (EPT/NON-RI)

28 Mar 2017 08:47

RNS Number : 7244A
W.H. Ireland Limited
28 March 2017
Β 

FORM 8.5 (EPT/NON-RI)

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

WH Ireland Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

FIH Group PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

FIH Group PLC

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

27/03/2017

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

Β 

Β 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

FIH Group PLC Ordinary 10p

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Β 

Β 

159

0.001

(2) Cash-settled derivatives:

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

TOTAL:

159

0.001

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p Ordinary

Β 

Purchase

200

311p

311p

Β 

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

28/03/2017

Contact name:

Michael Wilkinson

Telephone number:

0161 819 8882

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FEOUWSBRBNAOURR
Date   Source Headline
7th Jul 20227:00 amRNSAppointment of Chief Financial Officer
5th Jul 20227:00 amRNSFinal Results
10th May 20227:00 amRNSFull Year Trading Update
9th May 20226:10 pmRNSDirector's Details
17th Dec 20214:39 pmRNSDirector and PDMR Dealings
13th Dec 202111:37 amRNSDirector and PDMR Dealings
6th Dec 20217:00 amRNSIssue of share awards and Director/PDMR dealings
3rd Dec 20219:13 amRNSReplacement - PDMR Dealing
3rd Dec 20217:00 amRNSPDMR Dealing
23rd Nov 20217:00 amRNSDirectorate Change
18th Nov 20217:00 amRNSNew £17.3m Housing Contract in the Falklands
10th Nov 20217:00 amRNSResults for the Six Months Ended 30 September 2021
5th Oct 20215:05 pmRNSHolding(s) in Company
5th Oct 20215:02 pmRNSHolding(s) in Company
9th Sep 20212:25 pmRNSResult of AGM
9th Sep 20217:00 amRNSAGM Statement
16th Aug 20214:34 pmRNSPosting of Annual Report & Notice of AGM
28th Jul 20212:12 pmRNSDirector/PDMR Shareholding
16th Jul 20212:38 pmRNSBlock listing Interim Review
8th Jul 20218:40 amRNSDirector and PDMR dealing
6th Jul 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSAppointment of Chief Financial Officer
9th Apr 20217:00 amRNSTrading Statement
4th Feb 202111:16 amRNSBlock Listing interim review
12th Nov 20207:00 amRNSResults for the six months to 30 September 2020
6th Oct 20203:15 pmRNSDirector/PDMR Shareholding
17th Sep 20203:34 pmRNSResult of AGM
17th Sep 20207:00 amRNSAGM Statement
20th Aug 20207:00 amRNSPosting of annual report and Notice of AGM
20th Jul 20204:45 pmRNSDirector/PDMR Shareholding
13th Jul 20207:00 amRNSBlock listing Interim Review
6th Jul 20202:00 pmRNSDirector/PDMR Shareholding
1st Jul 20201:30 pmRNSDirector/PDMR Shareholding
1st Jul 20201:15 pmRNSDirector/PDMR Shareholding
23rd Jun 20207:00 amRNSFinal Results
31st Mar 20207:00 amRNSFull Year Trading and COVID-19 Update
13th Jan 20207:00 amRNSBlock Listing Six Monthly Return
13th Nov 20197:00 amRNSAppointment of Non-Executive Director
12th Nov 20197:00 amRNSInterim results: 6 months ended 30 September 2019
24th Sep 20194:26 pmRNSDirector and PDMR dealing
5th Sep 20193:33 pmRNSResult of AGM
5th Sep 20197:00 amRNSAGM Statement
15th Aug 20193:36 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSBlock Listing Six Monthly Return
10th Jul 20191:55 pmRNSDirector's and PDMR's dealing
10th Jul 20197:00 amRNSNew debt facilities agreed & new commercial flight
8th Jul 20197:00 amRNSPosting of Annual Report and Notice of AGM
5th Jul 20191:24 pmRNSIssue of share awards under LTIP and PDMR dealings
19th Jun 20193:18 pmRNSExercise of Options, Director/PDMR and TVR
17th Jun 201911:35 amRNSDirector/PDMR Dealing, exercise & grant of options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.